Space experiments aim to improve cancer treatment methods

Researchers are conducting new experiments on the International Space Station to develop a cancer treatment using Janus base nanotubes. These nanoparticles can deliver interleukin-12, a protein that boosts the immune response against tumors, while minimizing side effects. Previous trials with interleukin-12 caused severe side effects in patients. The new approach aims to encapsulate the protein in the nanotubes, allowing it to target tumors more effectively without harming healthy tissue. This is the team's seventh experiment in space, supported by a $1.9 million grant. They are also collaborating with Eascra Biotech to commercialize the nanotube production method, which could reduce costs to about 30 cents per dose.